|
MechanismNS5B polymerase inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with B&C Pharma Co. Limited
0 Patents (Medical) associated with B&C Pharma Co. Limited
100 Deals associated with B&C Pharma Co. Limited
100 Translational Medicine associated with B&C Pharma Co. Limited